Search filters

List of works by Miriam Molina-Arcas

3'-Azido-2',3'-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytes.

scientific article published on January 2006

A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum.

scientific article published on 30 September 2008

Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs

scientific article

Cell entry and export of nucleoside analogues

scientific article

Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells.

scientific article published on 13 October 2007

Complex regulation of nucleoside transporter expression in epithelial and immune system cells

scientific article

Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS-mutant lung cancer

scientific article published on March 2013

Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies

scientific article published on 22 May 2012

Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer

scientific article published on 01 September 2019

Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells

scientific article published in January 2005

Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells

scientific article published on 27 November 2007

Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma.

scientific article published on July 2006

Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia

scientific article (publication date: 15 March 2003)

How to Fool a Wonder Drug: Truncate and Dimerize

Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells.

scientific article published on 11 September 2006

Hypoxia and P1 receptor activation regulate the high-affinity concentrative adenosine transporter CNT2 in differentiated neuronal PC12 cells

scientific article published on September 2013

Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells

scientific article

Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1).

scientific article

Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.

scientific article

Nucleoside transporter proteins

scientific article published in October 2009

Nucleoside transporters in chronic lymphocytic leukaemia

scientific article published on March 2004

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.

scientific article published on 5 December 2017

Physiological and pharmacological roles of nucleoside transporter proteins

scientific article

RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance

scientific article published on 27 June 2019

RAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expression

scientific article

Role of nucleoside transporters in nucleoside-derived drug sensitivity

scientific article published in June 2010

SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers

scientific article published on 10 June 2019

The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer

scientific article

The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs

scientific article published on 26 April 2010

Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3

scientific journal article

Paulina is supported by:

About Paulina

Help